Laure Aurelian
#167,263
Most Influential Person Now
Virologist and immunologist
Laure Aurelian's AcademicInfluence.com Rankings
Laure Aurelianbiology Degrees
Biology
#13618
World Rank
#17172
Historical Rank
Virology
#342
World Rank
#349
Historical Rank
Immunology
#949
World Rank
#973
Historical Rank
Download Badge
Biology
Laure Aurelian's Degrees
- PhD Virology University of California, San Francisco
- Doctorate Immunology Harvard University
Why Is Laure Aurelian Influential?
(Suggest an Edit or Addition)Laure Aurelian's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. (1986) (224)
- Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. (2003) (138)
- Binge alcohol drinking is associated with GABAA α2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala (2011) (135)
- Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. (1989) (120)
- The association of genital herpesvirus with cervical atypia and carcinoma in situ. (1970) (115)
- The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Blocks Apoptosis in Hippocampal Neurons, Involving Activation of the MEK/MAPK Survival Pathway (2002) (111)
- Herpesvirus Type 2 Isolated from Cervical Tumor Cells Grown in Tissue Culture (1971) (105)
- The Herpes Simplex Virus Type 2 R1 Protein Kinase (ICP10 PK) Functions as a Dominant Regulator of Apoptosis in Hippocampal Neurons Involving Activation of the ERK Survival Pathway and Upregulation of the Antiapoptotic Protein Bag-1 (2003) (99)
- A Novel Human Gene Similar to the Protein Kinase (PK) Coding Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Codes for a Serine-Threonine PK and Is Expressed in Melanoma Cells* (2000) (95)
- Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) (1989) (92)
- Ras-GAP Binding and Phosphorylation by Herpes Simplex Virus Type 2 RR1 PK (ICP10) and Activation of the Ras/MEK/MAPK Mitogenic Pathway Are Required for Timely Onset of Virus Growth (2000) (92)
- Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma. (1970) (92)
- Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. (1999) (90)
- Antibody to genital herpes simplex virus: association with cervical atypia and carcinoma in situ. (1970) (89)
- THE MULTIPLICATION OF HERPES SIMPLEX VIRUS. I. THE PROGRAMMING OF VIRAL DNA DUPLICATION IN HEP-2 CELLS. (1963) (87)
- Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2. (1980) (85)
- Antibody to HSV-2 Induced Tumor Specific Antigens in Serums from Patients with Cervical Carcinoma (1973) (84)
- Control of ribonucleic acid function by oligonucleoside methylphosphonates. (1985) (82)
- CRF-Amplified Neuronal TLR4/MCP-1 Signaling Regulates Alcohol Self-Administration (2015) (82)
- Virus-Specific Immunity in Neonatal and Adult Mouse Rotavirus Infection (1983) (81)
- Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets. (1982) (79)
- Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I (2018) (76)
- Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2 (1989) (74)
- Oncolytic viruses as immunotherapy: progress and remaining challenges (2016) (73)
- Synthesis and preliminary pharmacological evaluation of new (+/-) 1,4-naphthoquinones structurally related to lapachol. (2002) (73)
- Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension (2018) (71)
- Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency. (1997) (67)
- Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABAA mechanism (2016) (65)
- Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. (1992) (64)
- Forced Expression of the H11 Heat Shock Protein Can Be Regulated by DNA Methylation and Trigger Apoptosis in Human Cells* (2003) (63)
- ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. I. CHARACTERIZATION OF VIRAL PROGENY FROM CO-OPERATIVE INFECTION WITH MUTANTS DIFFERING IN CAPACITY TO MULTIPLY IN CANINE CELLS. (1965) (62)
- Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. (1997) (61)
- A comparison of the toxinological characteristics of two Cassiopea and Aurelia species. (2001) (61)
- Herpes Simplex Virus Type 2 Vaccines: New Ground for Optimism? (2004) (59)
- Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice. (1987) (56)
- ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. II. ALTERNATIVE SUPPRESSION OF SYNTHESIS OF INTERFERON AND VIRAL CONSTITUENTS. (1965) (56)
- CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). (2005) (54)
- Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D. (1987) (53)
- Virions and antigens of herpes virus type 2 in cervical carcinoma. (1973) (53)
- Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain (2019) (53)
- The PK Domain of the Large Subunit of Herpes Simplex Virus Type 2 Ribonucleotide Reductase (ICP10) Is Required for Immediate-Early Gene Expression and Virus Growth (1998) (52)
- Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice. (2006) (52)
- Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10). (1999) (51)
- THE HOST RANGE OF HERPES SIMPLEX VIRUS; INTERFERON, VIRAL DNA, AND ANTIGEN SYNTHESIS IN ABORTIVE INFECTION OF DOG KIDNEY CELLS. (1964) (51)
- Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs (1980) (51)
- Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune Evasion* (2012) (51)
- Understanding the Pathogenesis of HSV-Associated Erythema multiforme (1998) (51)
- The HSV-2 mutant ΔPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins (2010) (50)
- A growth and latency compromised herpes simplex virus type 2 mutant (ICP10DeltaPK) has prophylactic and therapeutic protective activity in guinea pigs. (2001) (46)
- Immortalization and neoplastic transformation of normal diploid cells by defined cloned DNA fragments of herpes simplex virus type 2. (1983) (46)
- Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors (1983) (46)
- Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11. (1984) (45)
- Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product. (1985) (43)
- Viruses and gynecologic cancers: Herpesvirus protein (ICP 10/AG‐4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity (1981) (42)
- Herpes simplex virus type 1-induced encephalitis has an apoptotic component associated with activation of c-Jun N-terminal kinase (2011) (41)
- Herpesvirus type 2-induced, tumor-specific antigen in cervical carcinoma. (1973) (41)
- The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). (1992) (40)
- Immunity to herpes simplex virus type 2: viral antigen-presenting capacity of epidermal cells and its impairment by ultraviolet irradiation. (1986) (40)
- Cellulose Acetate Phthalate (CAP): An ‘Inactive” Pharmaceutical Excipient with Antiviral Activity in the Mouse Model of Genital Herpesvirus Infection (1999) (39)
- The transmembrane domain of the large subunit of HSV-2 ribonucleotide reductase (ICP10) is required for protein kinase activity and transformation-related signaling pathways that result in ras activation. (1994) (38)
- Antiviral effect of oligo(nucleoside methylphosphonates) complementary to the herpes simplex virus type 1 immediate early mRNAs 4 and 5. (1993) (38)
- Valproic acid induces neuronal cell death through a novel calpain‐dependent necroptosis pathway (2015) (38)
- Herpes simplex virus type 2 encodes a heat shock protein homologue with apoptosis regulatory functions. (2005) (38)
- HSV-induced apoptosis in herpes encephalitis. (2005) (36)
- The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity (2007) (36)
- A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli. (1991) (35)
- Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK. (2002) (35)
- Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). (1990) (34)
- Proteins of herpesvirus type 2: I. Virion, nonvirion, and antigenic polypeptides in infected cells. (1976) (34)
- Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
- Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity. (1985) (33)
- Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer. (1976) (33)
- Rabbit cardiomyopathy associated with a virus antigenically related to human coronavirus strain 229E. (1979) (33)
- AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). (1997) (32)
- Recurrent eruptions following unusual solitary coelenterate envenomations. (1987) (32)
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
- ATP and SH3 Binding Sites in the Protein Kinase of the Large Subunit of Herpes Simplex Virus Type 2 of Ribonucleotide Reductase (ICP10)* (1996) (31)
- Proteins of herpesvirus type 2. II. Studies demonstrating a correlation between a tumor-associated antigen (AG-4) and a virion protein. (1976) (30)
- Inhibition of herpes simplex virus replication by antisense oligo-2'-O-methylribonucleoside methylphosphonates. (1995) (29)
- An Approach to Chemotherapy Based on Base Sequence Information and Nucleic Acid Chemistry Matagen (Masking Tape for Gene Expression) (1987) (29)
- TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation (2016) (29)
- Cell-mediated immune response to herpes simplex virus: type-specific lymphoproliferative responses in lymph nodes draining the site of primary infection. (1976) (29)
- Immunodiagnostic potential of a virus‐coded, tumor‐associated antigen (AG‐4) in cervical cancer (1977) (27)
- Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro. (1987) (27)
- Intracellular internalization and signaling pathways triggered by the large subunit of HSV-2 ribonucleotide reductase (ICP10). (1995) (27)
- The large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is associated with the virion tegument and has PK activity. (1997) (27)
- A novel gene expressed in human keratinocytes with long-term in vitro growth potential is required for cell growth. (2001) (26)
- Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation. (1992) (26)
- Possible role of Herpesvirus hominis, type 2, in human cervical cancer. (1972) (26)
- Cutaneous ultraviolet radiation inhibits herpes simplex virus-induced lymphoproliferation in latently infected subjects. (1994) (26)
- ΔPK oncolytic activity includes modulation of the tumour cell milieu. (2016) (25)
- IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells. (1976) (25)
- Overload of the heat-shock protein H11/HspB8 triggers melanoma cell apoptosis through activation of transforming growth factor-β-activated kinase 1 (2007) (25)
- Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells. (1974) (25)
- Multi‐targeted neuroprotection by the HSV‐2 gene ICP10PK includes robust bystander activity through PI3‐K/Akt and/or MEK/ERK‐dependent neuronal release of vascular endothelial growth factor and fractalkine (2010) (24)
- Proteins of herpesvirus type 2. III. Isolation and immunologic characterization of a large molecular weight viral protein. (1978) (24)
- Nonionic Oligonucleotide Analogs (Matagen™) as Anticodic Agents in Duplex and Triplex Formation (1992) (24)
- Immediate early and functional AP-1 cis-response elements are involved in the transcriptional regulation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). (1992) (24)
- Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma (2014) (23)
- The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections (1990) (23)
- Microhemorrhage-associated tissue iron enhances the risk for Aspergillus fumigatus invasion in a mouse model of airway transplantation (2018) (23)
- Herpes simplex virus type 2 growth and latency reactivation by cocultivation are inhibited with antisense oligonucleotides complementary to the translation initiation site of the large subunit of ribonucleotide reductase (RR1). (2000) (23)
- "The Herpesvirus hypothesis"--are Koch's postulates satisfied? (1981) (23)
- The growth compromised HSV-2 mutant ΔRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures (2006) (23)
- Replication of canine herpesvirus. II. Virus development and release in infected dog kidney cells. (1969) (22)
- Longitudinal Study of a Patient with Herpes-simplex-Virus-Associated Erythema multiforme: Viral Gene Expression and T Cell Repertoire Usage (1999) (22)
- Immune responses to herpes simplex virus in guinea pigs (footpad model) and mice immunized with vaccinia virus recombinants containing herpes simplex virus glycoprotein D. (1991) (22)
- Expression of Herpes Simplex Virus Type 2 Protein ICP10 PK Rescues Neurons from Apoptosis Due to Serum Deprivation or Genetic Defects (2002) (22)
- Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease. (1989) (22)
- Traveler's diarrhea associated with rotavirus infection: analysis of virus-specific immunoglobulin classes (1981) (21)
- HSV-2 Antigens Absent from Biopsied Cervical Tumor Cells: A Model Consistent with Latency 1 (1972) (21)
- Restored expression of the atypical heat shock protein H11/HspB8 inhibits the growth of genetically diverse melanoma tumors through activation of novel TAK1-dependent death pathways (2012) (21)
- Neurosteroid allopregnanolone (3α,5α-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors (2021) (20)
- 3-Hydroxyphthaloyl β-Lactoglobulin. IV. Antiviral Activity in the Mouse Model of Genital Herpesvirus Infection (1998) (20)
- Herpes simplex virus type 2: unique biological properties include neoplastic potential mediated by the PK domain of the large subunit of ribonucleotide reductase. (1998) (20)
- ΔRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis (2008) (19)
- Acute skin eruptions that are positive for herpes simplex virus DNA polymerase in patients with stem cell transplantation: a new manifestation within the erythema multiforme reactive dermatoses. (2008) (19)
- The Levels of H11/HspB8 DNA Methylation in Human Melanoma Tissues and Xenografts Are a Critical Molecular Marker for 5-Aza-2′-Deoxycytidine Therapy (2011) (18)
- Antigen-specific immune-suppressor factor in herpes simplex virus type 2 infections of UV B-irradiated mice (1988) (18)
- Binge Drinking: In Search of its Molecular Target via the GABAA Receptor (2011) (18)
- Synergistic antiviral activities of oligonucleoside methylphosphonates complementary to herpes simplex virus type 1 immediate-early mRNAs 4, 5, and 1 (1994) (18)
- Protection from herpes simplex virus type 2 is associated with T cells involved in delayed type hypersensitivity that recognize glycosylation-related epitopes on glycoprotein D. (1992) (18)
- Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma. (1974) (18)
- The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase‐3 activation and XIAP up‐regulation (2007) (18)
- Expression analysis and chromosome location of a novel gene (H11) associated with the growth of human melanoma cells. (2001) (18)
- ICP10PK inhibits calpain-dependent release of apoptosis-inducing factor and programmed cell death in response to the toxin MPP+ (2008) (18)
- Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma. (1974) (18)
- Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls. (1976) (17)
- Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity. (1989) (17)
- Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production. (1983) (17)
- Expression of herpes simplex virus glycoprotein D on antigen presenting cells infected with vaccinia recombinants and protective immunity (1988) (17)
- NF-κB-Binding Proteins Induced by HSV-1 Infection of U937 Cells Are Not Involved in Activation of Human Immunodeficiency Virus (1993) (16)
- Experimental study of the disease of the corneal stroma caused by herpes simplex virus. (1966) (16)
- Coelenterate venom research 1991-1995: clinical, chemical and immunological aspects. (1996) (15)
- The Herpes Simplex Virus Gene Pol Expressed in Herpes-Associated Erythema Multiforme Lesions Upregulates/Activates SP1 and Inflammatory Cytokines (2007) (15)
- Augmentation of natural immune defence mechanisms and therapeutic potential of a mismatched double-stranded polynucleotide in cutaneous herpes simplex virus type 2 infection. (1987) (15)
- Lymphokine activity in coelenterate envenomation. (1986) (15)
- Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections. (1978) (15)
- Neoplastic transformation of cultured Syrian hamster embryo cells by DNA of herpes simplex virus type 2 (1979) (15)
- The cervical tumor-associated antigen (ICP-10/AG-4) is encoded by the transforming region of the genome of herpes simplex virus type 2. (1985) (14)
- H11/HspB8 and Its Herpes Simplex Virus Type 2 Homologue ICP10PK Share Functions That Regulate Cell Life/Death Decisions and Human Disease (2012) (14)
- Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs. (1980) (14)
- Sexually transmitted cancers? The case for genital herpes. (1976) (14)
- Aberrant DNA Methylation Silences the Novel Heat Shock Protein H11 in Melanoma but Not Benign Melanocytic Lesions (2006) (13)
- Oncolytic virotherapy: the questions and the promise. (2013) (13)
- Genital herpes virus findings in relation to cervical neoplasia. (1970) (13)
- The GABAA Receptor α2 Subunit Activates a Neuronal TLR4 Signal in the Ventral Tegmental Area that Regulates Alcohol and Nicotine Abuse (2018) (12)
- Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity (2017) (12)
- Focus formation and neoplastic transformation by herpes simplex virus type 2 inactivated intracellularly by 5-bromo-2'-deoxyuridine and near UV light (1981) (12)
- Three Yugoslav herpes simplex viruses: biologic and antigenic properties and formation of giant cells in vitro by a cervical isolate. (1974) (12)
- Leucine repeats in the large subunit of herpes simplex virus type 2 ribonucleotide reductase (RR; ICP10) are involved in RR activity and subunit complex formation. (1991) (12)
- Herpes simplex virus type 2 and cervical cancer. (1984) (12)
- Fetal bovine serum inhibits hepatitis C virus attachment to host cells. (2013) (11)
- Expression of herpesvirus-induced antigens in human cervical cancer (1981) (11)
- Growth‐compromised HSV‐2 vector ΔRR protects from N‐methyl‐D‐aspartate‐induced neuronal degeneration through redundant activation of the MEK/ERK and PI3‐K/Akt survival pathways, either one of which overrides apoptotic cascades (2008) (11)
- Effect of environmental conditions on formation and release of canine herpesvirus in infected canine kidney cells. (1968) (11)
- Herpesviruses, the Immune System, and AIDS (2011) (11)
- Proteins of herpesvirus type 2. V. Isolation and immunologic characterization of two viral proteins in a virus-specific antigenic fraction. (1979) (11)
- Letter to Dermatology (1999) (11)
- The oncolytic virus ΔPK has multimodal anti-tumor activity. (2016) (10)
- GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance (2019) (10)
- The protein kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) fused to the extracellular domain of the epidermal growth factor receptor is ligand-inducible. (1996) (10)
- Fluorescence-activated separation of cervical abnormal cells using herpesvirus antigenic markers. (1979) (10)
- Two populations of herpes virus virions which appear to differ in physical properties and DNA composition. (1966) (10)
- Correspondence regarding M.V. Kim et al. "Some properties of human small heat shock protein Hsp22 (H11 or HspB8)". (2004) (8)
- Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. (1984) (8)
- The hsv-2 la-1 oncoprotein is a member of a novel family of serine threonine receptor kinases. (1995) (8)
- Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls. (1978) (8)
- Herpes Simplex Viruses: General Features (2008) (8)
- Factors affecting the growth of canine herpesvirus in dog kidney cells. (1969) (8)
- Clinical and subclinical HSV infection resulting from exposure to asymptomatic patients (1990) (8)
- Ultraviolet light and immunity to coelenterate venom. (1996) (7)
- An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia. (1980) (7)
- Transformation and Mutagenic Effects Induced by Herpes Simplex Virus Types 1 and 2 (1995) (7)
- Herpesvirus antigens as markers for cervical cancer. (1981) (7)
- Frequent detection of herpes simplex virus antigen in skin and peripheral blood CD34+ mononuclear cells from patients with graft-versus-host disease. (2013) (7)
- Herpes simplex virus-mediated activation of human immunodeficiency virus is inhibited by oligonucleoside methylphosphonates that target immediate-early mRNAs 1 and 3. (1996) (7)
- Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1 (2005) (7)
- Rotavirus-associated traveler's diarrhea: neutralizing antibody in asymptomatic infections (1983) (6)
- Herpes simplex viruses. (2009) (6)
- Papillomavirus trans-activator protein E2 activates expression from the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2. (1990) (6)
- Current understanding of herpes simplex virus-associated erythema multiforme (2008) (6)
- Human immunosuppression induced by sea nettle (Chrysaora quinquecirrha) venom. (1991) (6)
- Antiviral activity of an oligo(nucleoside methylphosphonate) that targets HSV-1 immediate-early pre-mRNA 4,5 is augmented by cotreatment with replication-defective adenovirus. (1995) (6)
- Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls. (1975) (6)
- Modified adenovirus penton base protein (UTARVE) as a non-replicating vector for delivery of antisense oligonucleotides with antiviral and/or antineoplastic activity. (2000) (6)
- Replication of Canine Herpesvirus (1969) (5)
- Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer. (1987) (5)
- Coitus and cancer. (1976) (5)
- Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia. (1998) (5)
- Performance and Use of a Ribonucleotide Reductase Herpes Simplex Virus Type-Specific Serological Assay (2004) (5)
- The GGTCA palindrome and cognate cellular factors in trans-regulation of human immunodeficiency virus long terminal repeat by herpes simplex virus. (1993) (5)
- Control of Gene Expression by Oligonucleoside Methylphosphonates (1985) (5)
- The "viruses of love" and cancer. (1974) (5)
- Acute Skin Graft-versus-Host Disease with Molecular Features Mimicking Herpes Simplex Virus-Associated Erythema Multiforme: Report of Three Cases (2013) (5)
- Phenotyping CCL2 Containing Central Amygdala Neurons Controlling Alcohol Withdrawal-Induced Anxiety (2020) (4)
- HERPES SIMPLEX VIRUSES (HERPESVIRIDAE) | General Features (1999) (4)
- Cross talk of signaling and apoptotic cascades in the CNS: target for virus modulation. (2005) (4)
- Expression and cellular compartmentalization of a herpes simplex virus type 2 protein (ICP 10) in productively infected and cervical tumor cells. (1983) (4)
- Microfluorometric quantitation of size, deoxyribonucleic acid and viral antigenic determinants in cells productively infected with HSV-2. (1979) (4)
- Search for herpes simplex virus 2 and human papillomavirus genetic expression in vulvar neoplasia. (1990) (4)
- Clinical and virological comparison of 3 patients with erythema multiforme. (1999) (4)
- Evidence for a Viral Etiology of Squamous Cell Carcinoma of the Cervix (1983) (3)
- Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: Interleukin-1 and interleukin-2 modifyin vitro responses (1984) (3)
- Inhibition of viral protein synthesis and infection by oligonucleoside methylphosphonates (ONMP) (1984) (3)
- MODULATION OF VIRUS‐SPECIFIC IMMUNITY IN VITRO BY THE ADDITION OF INTERLEUKIN‐1 AND INTERLEUKIN‐2 IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME a (1984) (2)
- Heat-shock protein induction by herpes simplex virus type 1 in MD canine kidney cells (1992) (2)
- HSV-2 Transformation: A Multistep Process Mediated by Distinct Mutagenic DNA Sequences and Viral Genes Includes Activation of the Ras/MEK/MAPK Mitogenic Pathway (2001) (2)
- Viruses and carcinoma of the cervix. (1991) (2)
- Herpes simplex virus diagnosis. Antigen detection by ELISA and flow microfluorometry. (1982) (2)
- Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements (2022) (2)
- Genital cancer and Langerhans cells. (1993) (2)
- Herpesvirus hominis: from latency to carcinogenesis? (1973) (2)
- Intracellular localization and serological identification of a HSV-2 protein in cervical cancer. (1986) (2)
- Immunity to jellyfish venoms: suppression of venom-induced immune responses in ultraviolet B-irradiated mice. (1993) (2)
- THE ROLE OF IMMUNOSUPPRESSION IN HERPES SIMPLEX VIRUS PATHOGENESIS AND ITS RELATIONSHIP TO AIDS (1990) (2)
- NF-kappa B-binding proteins induced by HSV-1 infection of U937 cells are not involved in activation of human immunodeficiency virus. (1993) (2)
- THE HSV VECTOR Δ RR DELIVERS THE ANTI-APOPTOTIC PROTEIN ICP10PK AND PREVENTS APOPTOSIS AND LOSS OF FUNCTION IN KAINIC ACID TREATED ORGANOTYPIC HIPPOCAMPAL CULTURES THROUGH ERK AND AKT ACTIVATION (2009) (1)
- Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10 (1991) (1)
- Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer. (1987) (1)
- Replication of Canine Herpesvirus (1969) (1)
- THE HSV-2 GENE ICP10PK: A FUTURE IN THE THERAPY OF NEURODEGENERATION (2012) (1)
- HSPB8 (heat shock 22kDa protein 8) (2014) (1)
- Herpesvirus infection: Inhibition of leukocyte migration inhibition factor production in the diagnosis of recurrent disease (1981) (1)
- Biologic and immunologic comparison of two HSV-2 variants (1974) (0)
- Factors affecting the growth of canine herpesvirus in dog kidney cells (1969) (0)
- 960. Forced Expression of the Heat Shock Protein H11 Causes Growth Arrest and Apoptosis of Melanoma Cells through TAK1 Activation and Inhibits Tumor Growth in Xenograft Models (2006) (0)
- HSPB 8 ( heat shock 22 kDa protein 8 ) (2014) (0)
- ILDS Newsletter No. 31 (2014) (0)
- Excitotoxicity induced neuronal cell loss is prevented by the HSV-2 vector ΔRR through activation of survival pathways and modulation of glial cells (2006) (0)
- Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): A viral disease with an autoimmune component. - eScholarship (2003) (0)
- 1069. The HSV-2 Vector ΔRR Prevents Excitotoxicity-Induced Neuronal Cell Loss through Activation of Survival Pathways and Glial Cell Modulation (2006) (0)
- Delayed-type hypersensitivity (dth) to murine rotavirus: reinfection induces suppression of the dth. Abstr. (1982) (0)
- Studies demonstrating the immunological identity of the tumour-associated antigen AG-4 with a virion envelope protein. (1978) (0)
- Endogenous Neurosteroid (3α,5α)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain (2019) (0)
- Gene Therapy for Optic nerve stroke (AION) (2004) (0)
- Abstract 600: The HSV-2 oncolytic virus ΔPK induces multiple death and inflammatory programs associated with inhibition of melanoma tumor growth (2011) (0)
- Ribonucleotide Reductase Gene in Herpes Simplex Virus Type 2 and Virus Pathogenicity (1994) (0)
- CHAPTER 13 – Sexually Transmitted Viruses (1978) (0)
- Is Human Papillomavirus a Primary Factor in the Causation of Cervical Neoplasia? Does Herpes Simplex Virus Play a Subordinate Role? (1989) (0)
- GABAAR α2-activated neuroimmune signal controls binge drinking and impulsivity through regulation of the CCL2/CX3CL1 balance (2019) (0)
- The herpes simplex virus type 2 gene ICP10PK prevents motor neuron degeneration and extends life in the SOD1G93A transgenic rat model of Amyotrophic lateral sclerosis through modulation of glia-neuron crosstalk (2013) (0)
- Detection of la-1 oncogene in paraffin-embedded cervical-cancer tissues by polymerase chain-reaction. (1994) (0)
- Recurrent HSV is associated with a suppression factor that modulates lymphokine activity (1984) (0)
- Mechanism of recurrent herpes infections and prospects for vaccination (1985) (0)
- Traveler's Diarrhea: Neutralizing Antibody inAsymptomatic Infections (1983) (0)
- Age-dependent Microglial Disease Phenotype Results in Functional Decline in Gut Macrophages (2022) (0)
- Protein KinaseActivity Associated withtheLargeSubunit of HerpesSimplex VirusType2Ribonucleotide Reductase (ICP1O) (1989) (0)
- Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells. (1974) (0)
- Recent advances in coelenterate venom research 1991–1995: Clinical, chemical and immunological aspects (1996) (0)
- Herpes Simplex Virus induced Stem Cell Differentiation and Association With Graft-Versus-Host Disease (GVHD) in Bone Marrow Transplant Recipients (2011) (0)
- Corrigendum to "Intranasal Administration of the Growth-compromised HSV-2 Vector ΔRR Prevents Kainate-induced Seizures and Neuronal Loss in Rats and Mice". (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Laure Aurelian?
Laure Aurelian is affiliated with the following schools:
